# Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia

> **NCT01795183** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 316 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** AMISULPRIDE

## Key facts

- **NCT ID:** NCT01795183
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2015-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795183, "Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01795183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*